Takayasu Arteritis

Incidence and onset information

Alternative names

Takayasu Arteritis Is also known as young female arteritis, aortic arch syndrome, pulseless disease.

Researches and researchers

Doctors, researchs, and experts related to Takayasu Arteritis extracted from public data.

Takayasu Arteritis Experts map

Current Researchs and researchers

• PARIS — Pr Loïc GUILLEVIN

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Manager of registry - Contact person of registry - Coordinator of research network
  
  

  • Institution/s:
    — CHU Paris Centre - Hôpital Cochin, Site Cochin
  • Research area/topic::
    

    GFEV: French study group on vasculitis - research organization on necrotising angeitis, systemic diseases and vaccinale research



• LÜBECK — Pr Wolfgang L. GROSS

  Investigator of research project - Manager of registry
  
  

  • Institution/s:
    — Universitätsklinikum Schleswig-Holstein - Campus Lübeck
  • Research area/topic::
    

    DCVAS: American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) - Study to develop new diagnostic and classification criteria for Primary Systemic Vasculitis



• BARCELONA — Dr María Cinta CID XUTGLA

  Principal investigator of clinical trial - Investigator of research project
  
  

  • Institution/s:
    — Hospital Clínic de Barcelona
  • Research area/topic::
    

    ACR/EULAR: endorsed study to develop new diagnostic and classification criteria for primary systemic vasculitis



• CAMBRIDGE — Dr David JAYNE

  Coordinator of expert centre - Principal investigator of clinical trial - Investigator of clinical trial - Coordinator of research network
  
  

  • Institution/s:
    — Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital
  • Research area/topic::
    

    EUVAS: European vasculitis study group



• CAMBRIDGE — Dr James PETERS

  Investigator of research project
  
  

  • Institution/s:
    — University of Cambridge
  • Research area/topic::
    

    An integrated genetic and proteomic approach to understanding cardiovascular disease aetiology

Takayasu Arteritis Recommended genes panels

Panel Name, Specifity and genes Tested/covered
IL12B Sequencing. By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States). IL12B Specificity 100 % Genes 34 %
Familial Atypical Mycobacteriosis (sequence analysis of IL12B gene). By CGC Genetics (Portugal). IL12B Specificity 100 % Genes 34 %
Psoriasis susceptibility type 11. By Centogene AG - the Rare Disease Company (Germany). IL12B Specificity 100 % Genes 34 %
Defects of phagocytosis Panel. By CeGaT GmbH (Germany). STAT1, TAZ, TCIRG1, TCN2, TERT, WAS, WIPF1, ACTB, VPS45, HPS3, HPS4, HAX1, HPS5, DTNBP1, CEBPE, HPS6, SBDS, SLC35C1, BLOC1S3, VPS13B , (...) View the complete list with 39 more genes Panel complete gene list STAT1, TAZ, TCIRG1, TCN2, TERT, WAS, WIPF1, ACTB, VPS45, HPS3, HPS4, HAX1, HPS5, DTNBP1, CEBPE, HPS6, SBDS, SLC35C1, BLOC1S3, VPS13B, FERMT3, CSF2RA, CSF3R, G6PC3, CTSC, CXCR4, CYBA, CYBB, USB1, JAGN1, MLPH, DNM2, LAMTOR2, SLC46A1, ELANE, FCGR3B, FPR1, ACKR1, ISG15, SLC37A4, GATA1, GATA2, GFI1, HFE, HPS1, IRF8, IFNGR1, IFNGR2, AP3B1, IL12B, IL12RB1, ITGB2, MPO, MYO5A, NCF1, NCF2, NCF4, RAB27A, RAC2 Close Specificity 2 % Genes 34 %
Invitae Mendelian Susceptibility to Mycobacterial Disease Panel. By Invitae (United States). STAT1, STAT2, ACP5, TYK2, SAMHD1, IRAK4, ADAR, CYBB, ISG15, GATA2, IRF8, IFNGR1, IFNGR2, IL12B, IL12RB1, MYD88 Specificity 7 % Genes 34 %
Invitae Primary Immunodeficiency Panel. By Invitae (United States). RMRP, RORC, SEMA3E, SH2D1A, SH3BP2, SLC7A7, SMARCAL1, BTK, STAT1, STAT2, STAT3, STAT5B, STIM1, STK4, STX11, STXBP2, TAPBP, TAZ, TBK1, TCN2 , (...) View the complete list with 187 more genes Panel complete gene list RMRP, RORC, SEMA3E, SH2D1A, SH3BP2, SLC7A7, SMARCAL1, BTK, STAT1, STAT2, STAT3, STAT5B, STIM1, STK4, STX11, STXBP2, TAPBP, TAZ, TBK1, TCN2, TERC, TERT, TINF2, TLR3, TNFRSF1A, TNFRSF4, FAS, CD27, TNFSF12, CD40LG, FASLG, TPP2, TRAF3, TREX1, ACP5, TYK2, UNG, WAS, WIPF1, FOXN1, ZAP70, ACTB, AICDA, TRAF3IP2, UNC93B1, ITCH, BLNK, NHP2, NOP10, LPIN2, VPS45, CASP10, CASP8, SPINK5, IL36RN, RBCK1, RTEL1, SAMHD1, CARD9, CARD11, NLRP3, IL17F, NLRC4, CARD14, CD3D, CD3E, CD3G, CD247, HAX1, CD79A, CD79B, CD8A, TRNT1, LRBA, DCLRE1B, DCLRE1C, TNFRSF13C, IRAK4, TMC6, TNFRSF13B, TICAM1, IL17RC, CEBPE, ADA2, RNASEH2A, ADA, IFIH1, DOCK8, ADAM17, LYST, TTC7A, SLC35C1, TMC8, CHD7, ZBTB24, VPS13B, COPA, ADAR, CORO1A, NLRP12, SLC29A3, UNC13D, FERMT3, CR2, RNASEH2C, CSF2RA, CSF3R, G6PC3, MOGS, CTLA4, ACD, CTPS1, CTSC, CXCR4, RNASEH2B, NHEJ1, CYBA, CYBB, ORAI1, CTC1, JAGN1, TMEM173, MAGT1, DKC1, EPG5, DNMT3B, LAMTOR2, DOCK2, CLPB, ELANE, FADD, AIRE, AK2, FPR1, ISG15, SLC37A4, GATA2, GFI1, TAP1, TAP2, NOD2, ICOS, IRF8, SP110, IFNGR1, IFNGR2, AP3B1, IGLL1, XIAP, IKBKB, IL10, IL10RA, IL10RB, IL12B, IL12RB1, IL17RA, IL1RN, IL21, IL21R, IL2RA, IL2RG, IL7R, FOXP3, IRF7, ITGB2, ITK, JAK3, LCK, LIG4, MALT1, MAP3K14, RHOH, MEFV, CIITA, MVK, MYD88, NBN, NCF2, NCF4, NFAT5, NFKB2, NFKBIA, PNP, ATM, BLOC1S6, PARN, PGM3, PIK3CD, PIK3R1, PLCG2, PMS2, B2M, POLE, PRF1, PRKCD, PRKDC, PSMB8, PSTPIP1, PTPRC, RAB27A, RAC2, RAG1, RAG2, BCL10, RFX5, RFXANK, RFXAP Close Specificity 1 % Genes 34 %
IL12B. By Fulgent Genetics Fulgent Genetics (United States). IL12B Specificity 100 % Genes 34 %
Primary Immunodeficiency Panel. By Blueprint Genetics (Finland). RMRP, RORC, CFB, BLM, SH2D1A, SLC7A7, SMARCAL1, SMARCD2, SRP72, BTK, STAT1, STAT2, STAT3, STAT5B, STIM1, STK4, STX11, STXBP2, TAPBP, TBX1 , (...) View the complete list with 253 more genes Panel complete gene list RMRP, RORC, CFB, BLM, SH2D1A, SLC7A7, SMARCAL1, SMARCD2, SRP72, BTK, STAT1, STAT2, STAT3, STAT5B, STIM1, STK4, STX11, STXBP2, TAPBP, TBX1, TCF3, TCN2, TERC, TERT, TFRC, THBD, TINF2, TNFAIP3, TNFRSF1A, TNFRSF4, CD40, FAS, CD27, CD40LG, FASLG, CD70, TREX1, SERPING1, ACP5, C1QA, C1QB, TYK2, C1QC, C1S, C2, UNG, USP18, WAS, WIPF1, WDR1, FOXN1, ZAP70, IKZF1, C3, ACTB, AICDA, BCL11B, TRAF3IP2, SAMD9, UNC93B1, SAMD9L, BACH2, BLNK, MRTFA, NLRP1, NHP2, NOP10, LPIN2, VPS45, CDCA7, CASP10, CASP8, SPINK5, IL36RN, RBCK1, RTEL1, SAMHD1, RNF31, CD19, CARD9, CARD11, NLRP3, NLRC4, CARD14, CD3D, CD3E, CD3G, CD247, CD59, HAX1, HYOU1, CD79A, CD79B, CD81, CD8A, NCSTN, COLEC11, TRNT1, LRBA, DCLRE1B, DCLRE1C, IRAK4, TMC6, TNFRSF13B, IL17RC, CEBPE, ADA2, RNASEH2A, ADA, CFTR, IFIH1, LAT, DDX58, DOCK8, SBDS, ADAM17, LYST, TTC7A, SLC35C1, CLCN7, TMC8, CHD7, ZBTB24, IRF2BP2, VPS13B, COPA, ADAR, CORO1A, NLRP12, SLC29A3, UNC13D, FERMT3, CR2, RNASEH2C, CSF2RA, CSF2RB, CSF3R, G6PC3, MOGS, CTLA4, ACD, OTULIN, CTPS1, CTSC, WRAP53, CXCR4, OFD1, RNASEH2B, NHEJ1, CYBA, CYBB, USB1, ORAI1, CTC1, CD55, RNF168, ERCC6L2, JAGN1, DNAJC21, CARMIL2, CFD, TMEM173, DGKE, MAGT1, DKC1, GINS1, EPG5, DNMT3B, LAMTOR2, DOCK2, PSENEN, SLC46A1, CLPB, ELANE, RNU4ATAC, EXTL3, FADD, AIRE, AK2, ISG15, G6PD, SLC37A4, GATA2, GFI1, TAP1, TAP2, HELLS, CFH, NOD2, ICOS, IRF8, CFI, SP110, IFNAR2, IFNGR1, IFNGR2, AP3B1, IGLL1, XIAP, IKBKB, IL10, IL10RA, IL10RB, IL12B, IL12RB1, IL17RA, IL1RN, IL21, IL21R, IL2RA, IL2RG, IL7R, FOXP3, ITGB2, ITK, JAK1, JAK3, KRAS, RPSA, LCK, LIG4, MALT1, MAP3K14, RHOH, MASP1, CD46, MEFV, ARPC1B, CIITA, MRE11, MSN, MTHFD1, MVK, MYD88, MYO5A, NBN, NCF1, NCF2, NCF4, NSMCE3, NFKB1, NFKB2, NFKBIA, PNP, ATM, NRAS, PARN, PEPD, CFP, PGM3, PIGA, PIK3CD, PIK3R1, PLCG2, PMS2, POLE, POLE2, PRF1, PRKCD, PRKDC, PSMB8, PSTPIP1, PTPRC, RAB27A, RAC2, RAG1, RAG2, RASGRP1, BCL10, RECQL4, RFX5, RFXANK, RFXAP Close Specificity 1 % Genes 34 %

Sources and references

You can check the following sources for additional information.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like VAN BUCHEM DISEASE, TYPE 2 GLYCOGEN STORAGE DISEASE V; GSD5 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2 IMMUNODEFICIENCY 23; IMD23 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISM MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4; MDDGB4